Vaccines continue to help keep millions safe despite an ever-changing adversary, and there is new hope in the form of treatments that may prevent the most severe outcomes when infections do occur. While science drives us forward, we are also focused on the common goal of finding ways to lower healthcare costs for patients.
Making sure that medicines are accessible and affordable for patients is a goal we all share. But Congress is considering a dangerous proposal that could jeopardize the development of lifesaving medicines, vaccines, and treatments. The proposal calls for implementation of a government price-setting model that could undermine Medicare protections that provide patients robust choice and access to the medicines they need.
Hear from Pfizer CEO and President Albert Bourla about the company’s planned response to the humanitarian crisis facing India as it battles a second wave of the coronavirus.